David Mangelsdorf

Last updated

David J. Mangelsdorf is an American biologist and chemist, currently the Alfred J. Gilman Distinguished Chair in Pharmacology, Raymond and Ellen Willie Distinguished Chair in Molecular Neuropharmacology at University of Texas Southwestern Medical Center. In 2008, he was elected to the National Academy of Sciences. He, along with Steven Kliewer, identified the ligands and physiologic functions of a number of orphan nuclear receptors that then discovered two new signaling pathways mediated by the endocrine factors FGF19 and FGF21, which has become a significant accomplishment in the field. He received BS degrees in biology and chemistry from Northern Arizona University in 1981 and a PhD in biochemistry from the University of Arizona in 1987. [1] [2] [3]

Related Research Articles

Ellen S. Vitetta is the director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas.

<span class="mw-page-title-main">Rod Rohrich</span>

Rod J. Rohrich, F.A.C.S. is a Dallas-based plastic surgeon, author and educator. He is the editor-in-chief of the journal Plastic and Reconstructive Surgery and a founding member of the Dallas Plastic Surgery Institute and the Alliance in Reconstructive Surgery.

<span class="mw-page-title-main">Barbara Barrett</span> American businesswoman, attorney and diplomat (born 1950)

Barbara McConnell Barrett is an American businesswoman, attorney and diplomat who served as the United States secretary of the Air Force from 2019 to 2021. She is also an instrument-rated pilot, and cattle and bison rancher.

<span class="mw-page-title-main">FGF19</span> Protein-coding gene in the species Homo sapiens

Fibroblast growth factor 19 is a protein that in humans is encoded by the FGF19 gene. It functions as a hormone, regulating bile acid synthesis, with effects on glucose and lipid metabolism. Reduced synthesis, and blood levels, may be a factor in chronic bile acid diarrhea and in certain metabolic disorders.

<span class="mw-page-title-main">FGF21</span> Protein-coding gene in the species Homo sapiens

Fibroblast growth factor 21 is a liver-secreted peptide hormone that in humans is encoded by the FGF21 gene. Together with FGF19 and FGF23, this protein is a member of the endocrine subgroup within the fibroblast growth factor (FGF) family. FGF21 is a potent, extracellularly acting metabolic regulator, whose action was discovered through in vitro phenotypic screening and diet manipulation studies in rodents., unlike canonical growth-stimulating FGFs known to stimulate mitosis, differentiation and angiogenesis in their target tissues, FGF21 exerts its action by activating FGF21 receptors located in the cell membrane of target cells. Each FGF21 receptor is composed of a transmembrane FGF receptor protein, and its complexing co-receptor β-Klotho. Loss of β-Klotho abolishes all effects of FGF21 in vitro and in vivo. In addition to its action as a hormone, FGF21 may be able to act in an autocrine fashion, or possibly also in a paracrine manner in the pancreas.

Joe G. N. "Skip" Garcia is an American pulmonary scientist, physician and academician.

<span class="mw-page-title-main">Frederick Grinnell (biologist)</span> American biologist

Frederick Grinnell is an American cell biologist, also known for his work in bioethics and science education. Currently, he is a Distinguished Teaching Professor and the Robert McLemore Professor of Medical Science in the department of cell biology at UT Southwestern Medical Center in Dallas, Texas. Grinnell took his undergraduate degree in chemistry at Clark University (1966) and Ph.D. in biochemistry at Tufts New England Medical Center (1970). Subsequently, he moved to Dallas for postdoctoral work in the UTSW Biochemistry Department. In 1972, he joined the UTSW faculty in the Department of Cell Biology where he has developed a multidisciplinary research and teaching program, on one hand doing scientific research and on the other explaining what doing research entails. For additional information see the Grinnell laboratory website.

Fibroblast growth factor 15 is a protein in mouse encoded by the Fgf15 gene. It is a member of the fibroblast growth factor (FGF) family but, like FGF19, FGF21 and FGF23, has endocrine functions. FGF19 is the orthologous protein in humans. They are often referred together as FGF15/19.

FGF15/19 refers to two orthologous fibroblast growth factors which share 50% aminoacid identity and have similar functions. FGF15 was described in the mouse; FGF19 was found in humans and other species. They share physiological functions and so are often referred to as FGF15/19 or as FGF15/FGF19.

Peter J. O'Donnell, Jr. was an American businessman, securities investor and philanthropist. From 1962 to 1969, he was the Texas Republican state chair. In 1963, he was also the national chair of the Draft Goldwater Committee.

Willis Maddrey is an American physician and internist specializing in diseases of the liver. He is a professor emeritus at the University of Texas Southwestern Medical Center.

Craig Rubin is an American medical scientist in internal medicine.

Steven Kliewer is an American biochemist, a significant figure in his field, currently the Nancy B. and Jake L. Hamon Distinguished Chair in Basic Cancer Research at University of Texas Southwestern Medical Center. In 2015, he was elected to the National Academy of Sciences. He, along with David Mangelsdorf, identified the ligands and physiologic functions of a number of orphan nuclear receptors that then discovered two new signaling pathways mediated by the endocrine factors FGF19 and FGF21, which has become a significant accomplishment in the field.

Kathleen Bell is an American physician, currently the Kimberly-Clark Distinguished Chair in Mobility Research.

Melanie Cobb is an American biochemist, currently the Jane and Bill Browning Jr. Chair in Medical Science at University of Texas Southwestern Medical Center.

Carol A. Tamminga is an American psychiatrist and neuroscientist, focusing in treating psychotic illnesses, such as schizophrenia, psychotic bipolar disorder, and schizoaffective disorder, currently the Lou and Ellen McGinley Distinguished Chair in Psychiatric Research and the Chief of the Translational Neuroscience Division in Schizophrenia at University of Texas Southwestern Medical Center. She has been Chair of the Department of Psychiatry at UTSW since 2008. She is an Elected Fellow of the National Academy of Medicine. She serves on the advisory boards of the Brain and Behavioral Research Foundation and of the National Institute of Mental Health (NIMH). In 2011 she was awarded the Lieber Prize for Outstanding Achievement in Schizophrenia Research. Tamminga led a study examining whether giving Prozac to fetuses with Down syndrome would improve the functioning of their brains. In her attempt to confirm psychiatric diagnoses biologically, she found "biotypes" or "clusters." Her current research involves mechanisms underlying schizophrenia, especially its most prominent symptoms, psychosis and memory dysfunction.

Roger H. Unger was an American physician known for his studies of the physiology of pancreatic islets. In particular the elucidation of the roles of insulin and glucagon in the regulation of normal blood glucose homeostasis and in the pathogenesis of diabetes, and the establishment of glucagon as a hormone. He was the Touchstone/West Distinguished Chair in Diabetes Research at University of Texas Southwestern Medical Center.

<span class="mw-page-title-main">Fouad Bashour</span> Cardiologist and academic

Fouad Bashour, MD, PhD (1924–2003) was a noted cardiologist and Ashbel Smith professor of medicine at the University of Texas Southwestern Medical Center.

<span class="mw-page-title-main">Kenneth Z. Altshuler</span> American psychiatrist and psychoanalyst (1929–2021)

Kenneth Z. Altshuler was an American psychiatrist and psychoanalyst. He was a Professor Emeritus of Psychiatry and the Chairman of the Department of Psychiatry at the University of Texas Southwestern Medical Center in Dallas.

Margaret A. Phillips is an American biologist who is the Sam G. Winstead and F. Andrew Bell Distinguished Chair in Biochemistry at the University of Texas Southwestern Medical Center. She was elected a Fellow of the National Academy of Sciences in 2021.

References

  1. "David Mangelsdorf". utsouthwestern.edu. Retrieved February 25, 2017.
  2. "Principal Investigators". utsouthwestern.edu. Retrieved February 25, 2017.
  3. "David Mangelsdorf". nasonline.org. Retrieved February 25, 2017.